Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pioglitazone in Pulmonary Hypertension Due to Chronic Lung Disease
NCT06336798Phase 2Recruiting
- Sponsor
- Emory University
- Start
- Dec 2024
- Primary completion
- Feb 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pioglitazone in pulmonary hypertension (PH), sponsored by Emory University. Started Dec 2024; status: recruiting.
02
Drugs
pioglitazone
03
Conditions
pulmonary hypertension (PH)
Beyond the preview
Go deeper on NCT06336798.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06336798.